Kura Oncology, Inc. ( KURA) - Key Metrics
KURA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.20 | -$0.92 | $1.33 | $1.31 |
| 2025Q3 | $0.24 | -$0.85 | -$0.92 | -$0.95 |
| 2025Q2 | $0.17 | -$0.75 | -$0.33 | -$0.35 |
| 2025Q1 | $0.16 | -$0.66 | -$0.82 | -$0.83 |
KURA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -2.82 |
| 2025Q3 | ? | -2.62 |
| 2025Q2 | ? | -1.91 |
| 2025Q1 | ? | -2.51 |
KURA
Price: $9.42
52 week price:
Earnings Per Share: -3.35 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 495600
Ebitda: -9.1 millionMarket Capitalization: 768.3 million